- Details
- Description
-
Packaging Size15mg*30tablets/Bottle
-
Strength15mg
-
CompositonDacomitinib
-
TreatmentEGFR Lung Cancer(มะเร็งปอด ชนิดไม่เซลล์เล็ก (NSCLC)
-
FormTablet
-
BrandPHODACO
-
Quantity Unit30Tablets/Bottle
-
ManufacturerPhokam 2
Drug Name: PHODACO 15
Generic Name: Dacomitinib Tablets / Dacomitinib
Dosage Form: Tablets
Dosage: 45 mg Oral, once a day
Packaging Specifications: 15 mg Tablets: 30 tablets/bottle
Drug Category: Tumor
indications: Epidermis Growth factor receptor (EGFR) exon 19 deletion mutation or exon 21 L858R substitution mutation for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
Approval number: 01 L 0839/21
https://en.phokam.com/pdf/PHODACO15.pdf